We are delighted to announce that the Ontario Brain Institute (OBI) is investing approximately $400,000 CAD in Damona Pharmaceuticals, to provide support to the company developing treatments for cognitive deficits in depression and other brain disorders.
DAMONA’s team is excited to engage with OBI, and thank them for their support.